Immune profile of head and neck squamous cell carcinoma (HNSCC) patients can be used to assessment of radiotherapy response: transcriptome-based analysis

被引：0
|
作者：
Teresiak, A. [1 ,2 ]
Kolenda, T. [1 ,2 ]
Braska, A. [1 ]
Kozlowska-Maslon, J. [1 ,2 ]
Mantaj, P. [4 ]
Grzejda, N. [1 ,3 ]
Guglas, K. [1 ,2 ]
Poter, P. [5 ]
Dudek, K. [1 ,6 ]
Regulska, K. [7 ]
Blizniak, R. [1 ]
Kazimierczak, U. [8 ]
Lamperska, K. [1 ,2 ]
机构：
[1] Greater Poland Canc Ctr, Canc Genet Lab, 15 Garbary St, PL-61866 Poznan, Poland
[2] Greater Poland Canc Ctr, Res & Implementat Unit, Garbary St, PL-61866 Poznan, Poland
[3] Adam Mickiewicz Univ, Inst Human Biol & Evolut, Fac Biol, Uniwersytetu Poznanskiego 6, PL-61614 Poznan, Poland
[4] Greater Poland Canc Ctr, Radiat Protect Dept, Garbary St 15, PL-61866 Poznan, Poland
[5] Greater Poland Canc Ctr, Dept Tumor Pathol, Garbary St, PL-61866 Poznan, Poland
[6] Poznan Univ Life Sci, Wojska Polskiego 28, PL-60637 Poznan, Poland
[7] Pharm Greater Poland Canc Ctr, Garbary St 15, PL-61866 Poznan, Poland
[8] Poznan Univ Med Sci, Chair Med Biotechnol, Dept Canc Immunol, 8 Rokietnicka St, PL-60806 Poznan, Poland
来源：
FEBS OPEN BIO | 2024年 / 14卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-26-092
引用
收藏
页码：286 / 287
页数：2
相关论文
共 50 条
  • [1] Expression of immune response biomarkers in head and neck squamous cell carcinoma (HNSCC) in irradiated area
    Pflumio, C.
    Thomas, J.
    Salleron, J.
    Faivre, J-C.
    Borel, C.
    Dolivet, G.
    Sastre-Garau, X.
    Geoffrois, L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [2] Clinicopathological Parameters and Biomarker Profile in a Cohort of Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
    Hashmi, Atif A.
    Bukhari, Ummara
    Aslam, Mahnoor
    Joiya, Rana Sajawal
    Kumar, Ravi
    Malik, Umair Arshad
    Zia, Shamail
    Khan, Abdur Rahim
    Saleem, Mubasshir
    Irfan, Muhammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [3] CTCAE-based comprehensive toxicity assessment following radical radiotherapy for head & neck squamous cell carcinoma (HNSCC)
    Noble, David
    Bates, Amy
    Scaife, Jessica
    Gemmill, Jo
    Benson, Richard
    Barnett, Gill
    Jefferies, Sarah
    Burnet, Neil
    Jena, Raj
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 15 - 16
  • [4] Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
    Rassamegevanon, Treewut
    Feindt, Louis
    Koi, Lydia
    Mueller, Johannes
    Freudenberg, Robert
    Loeck, Steffen
    Sihver, Wiebke
    Cevik, Enes
    Kuehn, Ariane Christel
    von Neubeck, Claere
    Linge, Annett
    Pietzsch, Hans-Juergen
    Kotzerke, Joerg
    Baumann, Michael
    Krause, Mechthild
    Dietrich, Antje
    CANCERS, 2021, 13 (22)
  • [5] The Use of Immune Regulation in Treating Head and Neck Squamous Cell Carcinoma (HNSCC)
    Wang, Che-Wei
    Biswas, Pulak Kumar
    Islam, Atikul
    Chen, Mu-Kuan
    Chueh, Pin Ju
    CELLS, 2024, 13 (05)
  • [6] Genomic determinants of response to pembrolizumab in head and neck squamous cell carcinoma (HNSCC).
    Haddad, Robert I.
    Seiwert, Tanguy Y.
    Chow, Laura Quan Man
    Gupta, Shilpa
    Weiss, Jared
    Gluck, Iris
    Eder, Joseph Paul
    Burtness, Barbara
    Tahara, Makoto
    Keam, Bhumsuk
    Kang, Hyunseok
    Muro, Kei
    Albright, Andrew
    Huang, Lingkang
    Ayers, Mark
    Mogg, Robin
    Cristescu, Razvan
    Cheng, Jonathan D.
    Mehra, Ranee
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Analysis of immune infiltrates in a genomically characterized clinical cohort of head and neck squamous cell carcinoma (HNSCC) patients (pts).
    Chau, Nicole Grace
    Li, Yvonne Y.
    Hung, Yin P.
    Hammerman, Peter S.
    Rodig, Scott J.
    Schoenfeld, Jonathan Daniel
    Margalit, Danielle Nina
    Lorch, Jochen H.
    Rabinowits, Guilherme
    Tishler, Roy B.
    Haddad, Robert I.
    Jo, Vickie Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Clinical implications of hyperprogression with immune checkpoint inhibitors in patients with head and neck squamous cell carcinoma (HNSCC).
    Economopoulou, Panagiota
    Spathas, Nikolaos Spiridon
    Papaxoinis, George
    Anastasiou, Maria
    Gkotzamanidou, Maria
    Kotsantis, Ioannis
    Gavrielatou, Niki
    Oikonomopoulos, Nikolaos
    Kirodimos, Euthymios
    Vagia, Elena Mihal
    Kavourakis, George
    Psyrri, Amanda
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] MRI Response Assessment during Radiotherapy for Head and Neck Squamous Cell Carcinoma.
    Peltenburg, B.
    Philippens, M.
    de Bree, R.
    Terhaard, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E740 - E741
  • [10] Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
    Economopoulou, Panagiota
    Anastasiou, Maria
    Papaxoinis, George
    Spathas, Nikolaos
    Spathis, Aris
    Oikonomopoulos, Nikolaos
    Kotsantis, Ioannis
    Tsavaris, Onoufrios
    Gkotzamanidou, Maria
    Gavrielatou, Niki
    Vagia, Elena
    Kyrodimos, Efthymios
    Gagari, Eleni
    Giotakis, Evangelos
    Delides, Alexander
    Psyrri, Amanda
    CANCERS, 2021, 13 (02) : 1 - 15
12345